Different effect of resveratrol to induction of apoptosis depending on the type of human cancer cells

Takashina,Michinori; Inoue,Sayaka; Tomihara,Kei; Tomita,Kengo; Hattori,Kohshi; Zhao,Qing-Li; Suzuki,Tokiko; Noguchi,Makoto; Ohashi,Wakana; Hattori,Yuichi

doi:10.3892/ijo.2017.3859

Different effect of resveratrol to induction of apoptosis depending on the type of human cancer cells

Authors:
- Michinori Takashina
- Sayaka Inoue
- Kei Tomihara
- Kengo Tomita
- Kohshi Hattori
- Qing-Li Zhao
- Tokiko Suzuki
- Makoto Noguchi
- Wakana Ohashi
- Yuichi Hattori
View Affiliations

Affiliations: Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan, Department of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan, Department of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo 113-8655, Japan, Department of Radiological Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan
Published online on: January 24, 2017 https://doi.org/10.3892/ijo.2017.3859
Pages: 787-797

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The effect of resveratrol on various human cancer cells was investigated with special focus on apoptotic cell death, in an attempt to further characterize its mechanism of action. There were great differences in the anti-viability effect of resveratrol between different types of human cancer cells. While the inhibition of cell viability by resveratrol was marked in U937 and MOLT-4 leukemia cells, resveratrol moderately inhibited cell viability in MCF-7 breast, HepG2 liver, and A549 lung cancer cells, and the effect was slight on cell viability in Caco-2, HCT116, and SW480 colon cancer cells. Following resveratrol treatment, U937 and MOLT-4 markedly increased the population of late apoptotic cells but MCF-7 and HepG2 underwent apoptosis with an increased population of early apoptosis, and resveratrol-induced DNA fragmentation was observed only in leukemic cells. Activation of sirtuin 1 and adenosine-monophosphate-activated protein kinase was not responsible for resveratrol-induced cancer cell death. Instead, resveratrol significantly reduced Akt activation with the downregulation of H-Ras, resulting in facilitation of Bax translocation to mitochondria in leukemic cells. This study suggests that resveratrol can induce apoptotic cell death in human leukemic cells to a greater extent than in human solid tumor cells via reducing Akt activation due to Ras downregulation.

View Figures

View References

1	Kopp P: Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol. 138:619–620. 1998. View Article : Google Scholar : PubMed/NCBI
2	Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
3	Bhat KPL, Kosmeder JW II and Pezzuto JM: Biological effects of resveratrol. Antioxid Redox Signal. 3:1041–1064. 2001. View Article : Google Scholar
4	Virgili M and Contestabile A: Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci Lett. 281:123–126. 2000. View Article : Google Scholar : PubMed/NCBI
5	Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR and Kim AL: Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 224:274–283. 2007. View Article : Google Scholar : PubMed/NCBI
6	Carter LG, D'Orazio JA and Pearson KJ: Resveratrol and cancer: Focus on in vivo evidence. Endocr Relat Cancer. 21:R209–R225. 2014. View Article : Google Scholar : PubMed/NCBI
7	Clément MV, Hirpara JL, Chawdhury SH and Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 92:996–1002. 1998.PubMed/NCBI
8	Tessitore L, Davit A, Sarotto I and Caderni G: Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis. 21:1619–1622. 2000. View Article : Google Scholar : PubMed/NCBI
9	Ding XZ and Adrian TE: Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas. 25:e71–e76. 2002. View Article : Google Scholar : PubMed/NCBI
10	Aziz MH, Nihal M, Fu VX, Jarrard DF and Ahmad N: Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther. 5:1335–1341. 2006. View Article : Google Scholar : PubMed/NCBI
11	Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ and Lin HY: Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol Cancer Ther. 5:2034–2042. 2006. View Article : Google Scholar : PubMed/NCBI
12	Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, Shen HF and Xie LP: Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 101:488–493. 2010. View Article : Google Scholar
13	Nakagawa H, Kiyozuka Y, Uemura Y, Senzaki H, Shikata N, Hioki K and Tsubura A: Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J Cancer Res Clin Oncol. 127:258–264. 2001. View Article : Google Scholar : PubMed/NCBI
14	Joe AK, Liu H, Suzui M, Vural ME, Xiao D and Weinstein IB: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res. 8:893–903. 2002.PubMed/NCBI
15	Shih A, Davis FB, Lin HY and Davis PJ: Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab. 87:1223–1232. 2002. View Article : Google Scholar : PubMed/NCBI
16	Roman V, Billard C, Kern C, Ferry-Dumazet H, Izard JC, Mohammad R, Mossalayi DM and Kolb JP: Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br J Haematol. 117:842–851. 2002. View Article : Google Scholar : PubMed/NCBI
17	Liang YC, Tsai SH, Chen L, Lin-Shiau SY and Lin JK: Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem Pharmacol. 65:1053–1060. 2003. View Article : Google Scholar : PubMed/NCBI
18	Liao PC, Ng LT, Lin LT, Richardson CD, Wang GH and Lin CC: Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J Med Food. 13:1415–1423. 2010. View Article : Google Scholar : PubMed/NCBI
19	Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin IN, Min DS, Woo JH, Chang JS, Passaniti A, et al: Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis. 22:1633–1639. 2001. View Article : Google Scholar : PubMed/NCBI
20	Wolter F, Akoglu B, Clausnitzer A and Stein J: Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr. 131:2197–2203. 2001.PubMed/NCBI
21	Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA and Gautam SC: Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr. 132:2076–2081. 2002.PubMed/NCBI
22	Mouria M, Gukovskaya AS, Jung Y, Buechler P, Hines OJ, Reber HA and Pandol SJ: Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome c release and apoptosis. Int J Cancer. 98:761–769. 2002. View Article : Google Scholar : PubMed/NCBI
23	Mahyar-Roemer M, Katsen A, Mestres P and Roemer K: Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. Int J Cancer. 94:615–622. 2001. View Article : Google Scholar : PubMed/NCBI
24	Huang C, Ma WY, Goranson A and Dong Z: Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis. 20:237–242. 1999. View Article : Google Scholar : PubMed/NCBI
25	Kuo PL, Chiang LC and Lin CC: Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci. 72:23–34. 2002. View Article : Google Scholar : PubMed/NCBI
26	Baur JA: Biochemical effects of SIRT1 activators. Biochim Biophys Acta. 1804:1626–1634. 2010. View Article : Google Scholar :
27	Sakata K, Kondo T, Mizuno N, Shoji M, Yasui H, Yamamori T, Inanami O, Yokoo H, Yoshimura N and Hattori Y: Roles of ROS and PKC-βII in ionizing radiation-induced eNOS activation in human vascular endothelial cells. Vascul Pharmacol. 70:55–65. 2015. View Article : Google Scholar : PubMed/NCBI
28	Inoue S, Arai N, Tomihara K, Takashina M, Hattori Y and Noguchi M: Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells. Eur J Pharmacol. 761:44–54. 2015. View Article : Google Scholar : PubMed/NCBI
29	Taguchi K, Sakata K, Ohashi W, Imaizumi T, Imura J and Hattori Y: Tonic inhibition by G protein-coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels. J Pharmacol Exp Ther. 349:199–208. 2014. View Article : Google Scholar : PubMed/NCBI
30	Tomita K, Takashina M, Mizuno N, Sakata K, Hattori K, Imura J, Ohashi W and Hattori Y: Cardiac fibroblasts: Contributory role in septic cardiac dysfunction. J Surg Res. 193:874–887. 2015. View Article : Google Scholar
31	Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 450:712–716. 2007. View Article : Google Scholar : PubMed/NCBI
32	Cardaci S, Filomeni G and Ciriolo MR: Redox implications of AMPK-mediated signal transduction beyond energetic clues. J Cell Sci. 125:2115–2125. 2012. View Article : Google Scholar : PubMed/NCBI
33	Gillies LA and Kuwana T: Apoptosis regulation at the mitochondrial outer membrane. J Cell Biochem. 115:632–640. 2014. View Article : Google Scholar : PubMed/NCBI
34	Tsuruta F, Masuyama N and Gotoh Y: The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem. 277:14040–14047. 2002. View Article : Google Scholar : PubMed/NCBI
35	Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N, Marrack P, Bratton DL and Henson PM: Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem. 279:21085–21095. 2004. View Article : Google Scholar : PubMed/NCBI
36	Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:727–736. 1995. View Article : Google Scholar : PubMed/NCBI
37	Franke TF, Kaplan DR, Cantley LC and Toker A: Direct regulation of the Akt proto-oncogene product by phosphati-dylinositol-3,4-bisphosphate. Science. 275:665–668. 1997. View Article : Google Scholar : PubMed/NCBI
38	Castellano E and Downward J: RAS interaction with PI3K: More than just another effector pathway. Genes Cancer. 2:261–274. 2011. View Article : Google Scholar : PubMed/NCBI
39	Castellano E and Santos E: Functional specificity of ras isoforms: So similar but so different. Genes Cancer. 2:216–231. 2011. View Article : Google Scholar : PubMed/NCBI
40	Bradamante S, Barenghi L and Villa A: Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev. 22:169–188. 2004. View Article : Google Scholar : PubMed/NCBI
41	Baur JA and Sinclair DA: Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov. 5:493–506. 2006. View Article : Google Scholar : PubMed/NCBI
42	Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M, Kozaki K, Akishita M, Ouchi Y and Kaneki M: Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene. 25:176–185. 2006.
43	Testa JR and Tsichlis PN: AKT signaling in normal and malignant cells. Oncogene. 24:7391–7393. 2005. View Article : Google Scholar : PubMed/NCBI
44	Yan J, Roy S, Apolloni A, Lane A and Hancock JF: Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem. 273:24052–24056. 1998. View Article : Google Scholar : PubMed/NCBI
45	Voice JK, Klemke RL, Le A and Jackson JH: Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J Biol Chem. 274:17164–17170. 1999. View Article : Google Scholar : PubMed/NCBI
46	Eisfeld AK, Schwind S, Hoag KW, Walker CJ, Liyanarachchi S, Patel R, Huang X, Markowitz J, Duan W, Otterson GA, et al: NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation. Proc Natl Acad Sci USA. 111:4179–4184. 2014. View Article : Google Scholar : PubMed/NCBI